143 related articles for article (PubMed ID: 35833828)
1. Synchronization of Cocrystal Dissolution and Drug Precipitation to Sustain Drug Supersaturation.
Cogo Machado T; Kavanagh ON; Gonçalves Cardoso S; Rodríguez-Hornedo N
Mol Pharm; 2022 Aug; 19(8):2765-2775. PubMed ID: 35833828
[TBL] [Abstract][Full Text] [Related]
2. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
Machado TC; Kuminek G; Cardoso SG; Rodríguez-Hornedo N
Eur J Pharm Sci; 2020 Sep; 152():105422. PubMed ID: 32531350
[TBL] [Abstract][Full Text] [Related]
3. Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior.
Cavanagh KL; Kuminek G; Rodríguez-Hornedo N
Mol Pharm; 2020 Nov; 17(11):4286-4301. PubMed ID: 32815731
[TBL] [Abstract][Full Text] [Related]
4. An
Mendis NP; Lakerveld R
Mol Pharm; 2023 Nov; 20(11):5486-5499. PubMed ID: 37882573
[TBL] [Abstract][Full Text] [Related]
5. Effects of Coformer and Polymer on Particle Surface Solution-Mediated Phase Transformation of Cocrystals in Aqueous Media.
Omori M; Watanabe T; Uekusa T; Oki J; Inoue D; Sugano K
Mol Pharm; 2020 Oct; 17(10):3825-3836. PubMed ID: 32870691
[TBL] [Abstract][Full Text] [Related]
6. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
[TBL] [Abstract][Full Text] [Related]
7. Control of Dissolution and Supersaturation/Precipitation of Poorly Water-Soluble Drugs from Cocrystals Based on Solubility Products: A Case Study with a Ketoconazole Cocrystal.
Kataoka M; Yonehara A; Minami K; Takagi T; Yamashita S
Mol Pharm; 2023 Aug; 20(8):4100-4107. PubMed ID: 37354097
[TBL] [Abstract][Full Text] [Related]
8. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
9. Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.
Huang Y; Kuminek G; Roy L; Cavanagh KL; Yin Q; Rodríguez-Hornedo N
Mol Pharm; 2019 Sep; 16(9):3887-3895. PubMed ID: 31318567
[TBL] [Abstract][Full Text] [Related]
10. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
Yamashita H; Sun CC
Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
12. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
[TBL] [Abstract][Full Text] [Related]
13. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition.
Shi K; Li M
Pharm Res; 2023 Aug; 40(8):2051-2069. PubMed ID: 37188904
[TBL] [Abstract][Full Text] [Related]
15. Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.
Chen YM; Rodríguez-Hornedo N
Cryst Growth Des; 2018 Mar; 18(3):1358-1366. PubMed ID: 30505243
[TBL] [Abstract][Full Text] [Related]
16. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.
Kuminek G; Cao F; Bahia de Oliveira da Rocha A; Gonçalves Cardoso S; Rodríguez-Hornedo N
Adv Drug Deliv Rev; 2016 Jun; 101():143-166. PubMed ID: 27137109
[TBL] [Abstract][Full Text] [Related]
17. Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH.
Vasoya JM; Shah AV; Serajuddin ATM
ADMET DMPK; 2019; 7(2):106-130. PubMed ID: 35350544
[TBL] [Abstract][Full Text] [Related]
18. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
Huang N; Rodríguez-Hornedo N
J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
[TBL] [Abstract][Full Text] [Related]
20. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
